Login / Signup
Dipica Haribhai
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Cell Surface
Acute Lymphoblastic Leukemia
Anti Inflammatory
Transcription Factor
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Adam S Chervin
,
Jennifer D Stone
,
Iwona Konieczna
,
Kelly M Calabrese
,
Ningyan Wang
,
Dipica Haribhai
,
Feng Dong
,
Michael K White
,
Luis E Rodriguez
,
Gail T Bukofzer
,
Paul A Ellis
,
Cormac P Cosgrove
,
Claudie Hecquet
,
Jerry D Clarin
,
Joann P Palma
,
Edward B Reilly
ABBV-184: A novel survivin-specific TCR/CD3 bispecific T cell engager is active against both solid tumor and hematological malignancies.
Molecular cancer therapeutics
(2023)